Progress, consensus and controversies in gynecological and obstetric screening: A narrative literature review

1. Wilson JM, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.

2. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2021.

3. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102-131. Available from: https://doi.org/10.1097/lgt.0000000000000525

4. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S , Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203. Available from: https://doi.org/10.1016/s2214-109x(19)30482-6

5. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, et al. Aaron B Caughey Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674–686. Available from: https://doi.org/10.1001/jama.2018.10897

6. Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e023788.

7. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205-2240. Available from: https://doi.org/10.1038/bjc.2013.177

8. Schoonenberg EH, et al. Digital breast tomosynthesis in population-based screening: systematic review and meta-analysis. Eur Radiol. 2021;31(7):4500-4512.

9. Mann RM, Athanasiou A, Baltzer PA, et al. Breast cancer screening in women with dense breasts: recommendations from the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32(4):2161-2171.

10. Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2023;61(1):127-143.

11. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302-314. Available from: https://doi.org/10.1002/uog.17484

12. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana V, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613-622. Available from: https://doi.org/10.1056/nejmoa1704559

13. Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis and management. Int J Gynaecol Obstet. 2019;145 Suppl 1:1-33.

14. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International Association of diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682. Available from: https://doi.org/10.2337/dc09-1848